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Plasmodium sporozoites develop within oocysts residing in the mosquito midgut. Mature sporozoites exit the oocysts,
enter the hemolymph, and invade the salivary glands. The circumsporozoite (CS) protein is the major surface protein of
salivary gland and oocyst sporozoites. It is also found on the oocyst plasma membrane and on the inner surface of the
oocyst capsule. CS protein contains a conserved motif of positively charged amino acids: region II-plus, which has been
implicated in the initial stages of sporozoite invasion of hepatocytes. We investigated the function of region II-plus by
generating mutant parasites in which the region had been substituted with alanines. Mutant parasites produced
normal numbers of sporozoites in the oocysts, but the sporozoites were unable to exit the oocysts. In in vitro as well,
there was a profound delay, upon trypsin treatment, in the release of mutant sporozoites from oocysts. We conclude
that the exit of sporozoites from oocysts is an active process that involves the region II-plus of CS protein. In addition,
the mutant sporozoites were not infective to young rats. These findings provide a new target for developing reagents
that interfere with the transmission of malaria.
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Introduction
The Plasmodium life cycle in the Anopheles mosquitoes begins
with the ingestion of a blood meal containing Plasmodium
gametocytes. After fertilization of the resulting gametes, the
zygotes transform into motile ookinetes that traverse the
midgutepithelium,reachthebasallamina,andthentransform
intooocysts.Theyoungoocyst,surroundedbyacapsuleandby
the basal lamina, undergoes multiple mitotic nuclear divisions
and progressively enlarges in size without cytokinesis. At the
same time, the cytoplasm is subdivided by membrane clefts
forming structures named ‘‘sporoblasts.’’ Later, uninucleate
sporozoites bud from the sporoblast membrane. The mature
oocyst is about 50 lm in diameter and contains thousands of
sporozoites. Sporozoites leave the oocysts asynchronously,
enter the hemolymph, and then invade the salivary glands
where they remain until they are injected, with the saliva, into
the skin of the mammalian host [1,2].
In order to reach the ﬂowing hemolymph, sporozoites must
traverse two physical barriers: the oocyst capsule and the
mosquito basal lamina. Because oocyst sporozoites display
limited movement [3], their egress from oocysts is generally
thought to be a passive process. Early ultrastructural
observations reveal the presence of small openings in the
capsule of mature oocysts and the basal lamina. Occasionally,
sporozoites are found ‘‘penetrating’’ these openings and
entering the hemolymph [4]. The oocyst capsule contains
laminin of mosquito origin and displays trans-glutaminase
activity probably of parasite origin [5,6]. In addition, the
inner surface of the capsule is covered with the Plasmodium
circumsporozoite (CS) protein [7–9].
The development of sporozoites in oocysts is CS dependent.
When the CS gene is deleted, the oocysts are devoid of mature
parasites [10]. To investigate the mechanisms leading to this
developmental arrest, we have generated Plasmodium berghei
parasites bearing different mutations in the CS coding region.
In one of the P. berghei CS mutants, we substituted the
positively charged amino acids of the conserved region II-plus
with alanines. Region II-plus is located at the 59 end of the
thrombospondin type 1 repeat (TSR) domain of CS protein.
Several in vitro observations strongly suggest that region II-
plus participates in the initial steps of sporozoite attachment
and invasion of the host’s hepatocytes via interaction with
heparansulfate proteoglycan (HSPGs) onthe host cells[11,12].
Here we show for the ﬁrst time that the mutation in region II-
plus of CS protein prevents the exit of sporozoites from
oocysts and progression of the Plasmodium lifecycle. In
addition, the mutant sporozoites are unable to infect rats.
Results/Discussion
Construction of CS-RIImut and CS-WT
A P. berghei clone with mutated region II-plus of CS protein
(R290A, K291A, R292A, and K293A) was obtained by
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defects in the locus associated with the recombination event,
a control clone, CS-WT, which produces wild-type CS
protein, was generated by the same method (pRCS-WT and
pRCS-RIImut, Figure 1A and 1B). A PstI site was introduced
in pRCS-RIImut in order to detect the presence of mutations
by PCR and Southern blot analysis [13]. The schematic
structure of CS and the sequence of region II-plus of wild-
type and mutant CS are shown in Figure 1C.
Genomic DNA from WT, CS-WT, and CS-RIImut were
digested with XbaI and PstI, and subjected to Southern blot
hybridization. WT displays a 7.9-kb band, whereas CS-WT
displays a 5.5-kb band and CS-RIImut a 2.2-kb band,
indicating that the CS-RIImut and CS-WT have a correct
recombination locus (Figure 1D). This was conﬁrmed by PCR
ampliﬁcation speciﬁc for recombinants (Figure 1E and 1F),
subsequent PstI digestion (Figure 1E), and by sequencing of
PCR products. The sequences of coding regions of wild-type
and mutant CS are as expected.
We cannot exclude the possibility that the substitution of
the four positively charged amino acids of region II-plus led
to secondary changes in the structure of CS protein.
CS-RIImut Sporozoites Do Not Exit from Oocysts
Groups of Anopheles stephensi mosquitoes were infected with
CS-WT, a clone of wild-type P. berghei NK65 strain (WT), and
two independent clones of CS-RIImut. CS-WT and WT are
identical; therefore, CS-WT was used as a wild type control in
all experiments. The numbers of oocysts and oocyst spor-
ozoites at 14 d after blood meal (post-infection [PI]) were very
similar in CS-WT and in the two mutant clones (Table 1).
However, profound differences were observed at later time
points. At day 16 and 18 PI, mutant infected mosquitoes
contained many more oocyst sporozoites compared to wild-
type infected ones (Figure 2A). In two other independent
feeding experiments, similar results were obtained at day 16
PI: 50,000 and 96,000 oocyst sporozoites/mosquito for CS-
RIImut, versus 35,000 and 75,000 oocyst sporozoites/mosquito
for CS-WT, respectively. By contrast, the hemolymph of
mosquitoes infected with CS-WT parasites contained many
more sporozoites compared to mosquitoes infected with
mutant parasites. CS-WT sporozoites entered the hemolymph
beginning at day 12 PI, and the peak numbers were reached
around day 18 PI. In contrast, even at 28 days PI, only
minimal numbers of CS-RIImut sporozoites were found in
the hemolymph (Figure 2B and 2C). Thus, the observed
increase in the numbers of CS-RIImut oocyst sporozoites
between days 14 and 18 is most likely a consequence of their
inability to be released in to the hemolymph.
CS-RIImut Sporozoites Display Normal Morphology and
Motility
The morphology of CS-RIImut sporozoites was analyzed by
immunoﬂuorescence assays (Figure 3A), transmission elec-
tron microscopy, and immuno-electron microscopy using
monoclonal antibodies (3D11) to the repeats of the CS
protein. (Figure 3B–3F). CS-RIImut did not display any
abnormalities in the sporozoite morphology during develop-
ment (Figure 3B). The detailed structure of the mutant
sporozoite surface is shown Figure 3C and 3D. The structures
of the trimembrane pellicle (plasma membrane and inner
membrane complex) and subpellicular microtubules are
indistinguishable from those of wild type. Patterns of CS
protein labeling in CS-WT and CS-RIImut sporozoites were
indistinguishable. In the mutants, very similar to wild type, CS
protein was detected on the surface of budding or fully
developed sporozoites (Figure 3A and 3E), and on the inner
surface of the capsule (Figure 3E and 3F) [2,14]. To compare
the amounts of CS protein in mutant and CS-WT parasites,
extracts of CS-WT and CS-RIImut oocyst sporozoites were
analyzed by Western blot (Figure 3G). The intensity of both
precursor (54 kDa) and mature (44 kDa) forms of CS [15], was
very similar in the WT and the mutant. The two bands appear
slightly smaller in the mutant as a result of the replacement of
four basic residues (R290, K291, R292, and K293) with
alanines. As a control we analyzed levels of TRAP (thrombo-
spondin-related anonymous protein), another sporozoite
surface protein [16], and found that it was not affected in
the CS mutant (Figure 3G). We conclude that the recombi-
nation event and mutations did not grossly affect CS protein
expression or stability.
It could be argued that the sporozoite exit from oocysts
requires sporozoite motility and that the motility is impaired
in the mutants. In fact, previous studies have shown that
sporozoite motility is neither required nor does it ensure the
exit of sporozoites from oocysts [14,17]. In contrast to the
circular gliding observed in salivary gland sporozoites,
movements of oocyst sporozoites are mostly limited to
stretching and back-and-forth gliding [3]. We observed that
approximately 3% CS-RIImut oocyst sporozoites display
discontinuous gliding motility, and approximately 10%–
15% display stretching and bending. The numbers are very
similar to those of CS-WT.
CS-RIImut Oocysts Are More Resistant to Proteolytic
Activity
Although CS-WT and CS-RIImut are morphologically
indistinguishable, develop equally well in mosquitoes, move
similarly, and contain equal levels of CS protein, sporozoite
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Synopsis
Malaria affects hundreds of millions of people, and kills at least 1
million children per year. The infective stages of the malaria
parasites, named ‘‘sporozoites,’’ are found in the salivary gland of
Anopheles mosquitoes, and are injected along with the saliva during
blood feeding. From the skin, sporozoites enter the blood
circulation and invade liver cells where the parasites multiply. When
they exit the liver, these parasites infect blood cells and can cause
severe symptoms. If ingested by mosquitoes, the blood-stage
parasites continue their lifecycle in the insect stomach. Thousands of
sporozoites are formed within a cyst-like structure (oocyst). The
sporozoites come out of the oocyst and infect the salivary gland,
where they remain until injected back into humans. Malaria
parasites are increasingly resistant to drugs, mosquitoes are difficult
to eliminate, and effective vaccines are not yet available. New tools
to combat malaria are urgently needed. One exciting approach,
although the application is in the distant future, is to release in
endemic areas genetically modified mosquitoes that are resistant to
parasite growth. This paper provides a new target for generating
these ‘‘transmission-block’’ mosquitoes and shows that the exit of
sporozoites from the oocysts is an active process that requires the
enzymatic digestion of components of the oocyst wall. If these
enzymes are inhibited in transgenic mosquitoes, sporozoites will
never reach the salivary gland.egress from mutant oocyst is profoundly defective. Little is
known of the process of sporozoite exit from oocysts, but
some information can be obtained from the erythrocytic
stages of the parasite. During development in the red blood
cells, malaria parasites reside inside a parasitophorous
vacuole. Merozoite egress requires the rupture of the para-
sitophorous vacuole and the membrane of the red blood cells.
Release of merozoites from infected erythrocytes requires
proteases and is inhibited by inhibitors of proteolytic
enzymes [18–20]. Plasmodium falciparum falcipain-2 (a cysteine
protease) cleaves erythrocyte membrane skeletal proteins at
late stages of parasite development [21], facilitating the
merozoite egress.
To examine the possible role of a proteolytic event in the
release of sporozoites from oocysts, we treated isolated
midguts from CS-WT– or CS-RIImut–infected mosquitoes
(14 days PI) with trypsin and measured the number of
released sporozoites (Figure 4). The lower temperature (25 8C)
was chosen to mimic natural conditions of oocyst develop-
ment in the mosquito midguts. In the absence of trypsin, very
few sporozoites were released from either CS-WT– or CS-
RIImut–infected midguts even after 3 h of incubation.
Treatment with trypsin for 40 min leads to a signiﬁcant
increase in the number of sporozoites released from CS-WT,
Figure 1. Gene Targeting at the CS Locus of P. berghei
(A and B) Replacement plasmid pRCS-WT and pRCS-RIImut, wild-type (WT) CS locus and recombinant locus. ORFs are symbolized by boxes. Small black
box in the CS ORF indicates the mutation in region II-plus (R290A, K291A, R292A, and K293A). A PstI site is introduced in the mutation site to
differentiate CS-RIImut from CS-WT. Thick lines indicate 59- and 39-UTRs of DHFR-TS; thin lines, 59- and 39UTRs of CS; dashed lines, plasmid vector
sequence. B, BamHI; K, KpnI; N, NotI; P, PstI; S, SacI; Xb, XbaI; Xh, XhoI.
Recombinant CS-WT or CS-RIImut was generated by double crossover occurring between the CS sequences in the KpnI-SacI fragment of plasmid pRCS-
WT or pRCS-RIImut and their homologous sequence in the wild-type CS genomic locus. The CS probe used in the genomic Southern hybridization is
symbolized by a thick dash-dot line. Restriction fragments of the wild type and of the expected recombinants are shown below the corresponding
locus. Locations of primers used for PCR are indicated in (B).
(C) Schematic structure of the CS protein and sequences of the region II-plus of wild-type and mutant CS.
(D) Genomic Southern hybridization of the wild-type P. berghei strain (WT), the recombinant lines, control (CS-WT), and mutant (CS-RIImut) parasites
upon digestion with XbaI and PstI, using a CS probe.
(E) PCR amplification with primers CS1 and PB103 of the expressed CS protein at the 59 recombinant locus in CS-RIImut and CS-WT. The WT is used as a
negative control (lack of recombination events). The amplicons (2.3 kb) were subjected to PstI restriction enzyme digestion (two fragments released, 1.6
and 0.7 kb) to examine the presence of mutation in CS-RIImut, which is absent in CS-WT.
(F) PCR amplification of the 39 recombinant locus using primers PB106 and CS4.
DOI: 10.1371/journal.ppat.0010009.g001
Table 1. Parasite Development in Mosquitoes
Clones Percent
Infected
Midguts
a
Oocyst/
Midgut
a
Midgut
Sporozoite/
Mosquito
b
Hemocoel
Sporozoite/
Mosquito
c
Salivary
Gland
Sporozoite/
Mosquito
d
CS-WT 94 115 16,000 4,200 17,500
CS-RIImut-1 94 158 23,000 14 0
CS-RIImut-2 71 85 12,000 55 0
Each experiment is based on an average of a minimum of 20 mosquitoes.
aParasite numbers are determined on day 10 PI.
bParasite numbers are determined on day 14 PI.
cParasite numbers are determined on day 16 PI.
dParasite numbers are determined on day 18 PI.
DOI: 10.1371/journal.ppat.0010009.t001
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Mutational Analysis of Region IIþ of CS Proteinbut not from CS-RIImut. Release of sporozoites from CS-
RIImut oocysts was achieved only after extended treatment
with trypsin. In Figure 4 we show the release at 14 d PI, but
identical results were observed with 18-d oocysts (data not
shown). This effect is trypsin speciﬁc, because the release of
sporozoites was abolished when the soybean trypsin inhibitor
was included in the incubation (data not shown).
These results indicated that the sporozoite egress from
oocysts is a protease-dependent process and that CS-RIImut
oocysts are more resistant to the trypsin treatment. CS is
detected on the inner surface of the oocyst capsule [7–9].
Therefore, on their way out from the oocysts, sporozoites
have to ﬁrst traverse the CS protein layer beneath the
capsule. The positively charged residues, arginines and
lysines, of region II-plus are preferred substrates for certain
cysteine proteases and serine proteases, such as trypsin.
Therefore, it is possible that proteolysis of the CS protein
layer underneath the capsule is required for sporozoite egress
and is abolished in the mutant in which region II-plus has
been substituted. Thus, a possible explanation for the defect
of the mutant sporozoite is that the substitutions made in the
region II-plus render CS protein more resistant to the
putative protease. Trypsin treatment of the oocysts most
likely cleaved the CS protein in many places, not only in
region II-plus, since lysines and arginines are very abundant
in the CS domains outside the repeats. Nevertheless, the
subtle mutations introduced in CS region II-plus resulted in a
clear difference in the kinetics of sporozoite release after
treatment with the enzyme.
The exit of sporozoites from oocysts is most likely a
stepwise process aimed at the sequential disruption of the
capsule and the mosquito-derived basal lamina. In P.
falciparum, PfCCp2 or PfCCp3, two secreted multidomain
putative adhesive proteins, play an essential role in spor-
ozoite release—in the absence of either protein, sporozoites
were not released from the oocysts—but their localization
and mechanism of action are unknown [22]. Our observations
suggest that proteolysis of CS protein that lies beneath the
capsule is likely to be an early event in sporozoite egress. Our
hypothesis is supported by a recent ﬁnding that a papain-like
cysteine protease egress cysteine protease 1 (ECP1) is
required for sporozoite egress from oocysts [23]. Members
of the papain family of cysteine proteases, similar to trypsin,
consistently attack peptide bonds formed by lysine and
arginine. We presume that ECP1 is only active when oocysts
are ‘‘mature’’ and the sporozoites are ready to enter the
hemolymph. At that particular time, only the CS protein that
is beneath the capsule, but not CS on the sporozoite surface,
is cleaved by ECP1, facilitating the egress of sporozoites from
the oocysts. A possible explanation for this selectivity is that
Figure 2. CS-RIImut Oocyst Sporozoites Are Not Released from the Midguts
Represented in each graph are the mean numbers of sporozoites per mosquito at different days PI. Each number is calculated based on an average of
20 mosquitoes.
(A) Numbers of oocyst sporozoites per mosquito from CS-WT– and CS-RIImut–infected mosquitoes. In CS-RIImut, the number of sporozoites increases
progressively until day 18 PI, whereas in CS-WT a plateau is reached at day 14.
(B) Numbers of sporozoites in the hemolymph from CS-WT– and CS-RIImut–infected mosquitoes from the same lot as in (A). CS-WT oocysts release
sporozoites into the hemolymph from day 12 to day 18 PI. The peak is around day 18 PI. In contrast, the hemolymph from CS-RIImut contains very few
sporozoites.
(C) In another feeding experiment, the number of hemolymph sporozoites from CS-WT and CS-RIImut infected mosquitoes were calculated from day 14
to day 28 PI. CS-WT releases sporozoites into the hemolymph up to day 28 PI, whereas CS-RIImut does not.
DOI: 10.1371/journal.ppat.0010009.g002
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Mutational Analysis of Region IIþ of CS ProteinFigure 3. Ultrastructure and CS Localization of CS-WT and CS-RIImut
(A) Immunofluorescence labeling of oocyst sporozoites from CS-WT and CS-RIImut at day 18 PI. Sporozoites were stained with anti-CS antibody and
detected by FITC-conjugated anti-IgG antibodies, without prior permeabilization.
(B) Transmission electron micrographs showing a CS-RIImut oocyst at day 14 PI. The oocyst is surrounded by a capsule and the mosquito basal lamina,
and contains sections of sporozoites with normal morphology. Fully developed sporozoites are found within the CS-RIImut oocyst. Sporozoites have
homogenous size and morphology. Scale bar represents 1 lm.
(C) Longitudinal section of the CS-RIImut sporozoite pellicle shows the plasma membrane, inner membrane complex, and an associated microtubule.
Scale bar represents 0.5 lm.
(D) Cross-section of a CS-RIImut sporozoite showing the trimembrane pellicle and subpellicular microtubules. Scale bar represents 0.5 lm.
(E) Immuno-electron micrographs showing CS localization in the CS-RIImut oocyst. CS protein is predominantly found on the surface of sporozoites and
the residual body, and on the inner surface of the capsule. Scale bar represents 1 lm.
(F) Enlarged picture of the CS-RIImut oocyst capsule. CS protein is detected on the inner surface of the capsule. Scale bar represents 1 lm.
(G) Western blot analysis of extracts from CS-WT (WT) and CS-RIImut (RII) oocyst sporozoites. Numbers of sporozoites loaded are indicated on the top of
each lane. Sporozoites were collected from oocysts in mosquito midguts at days 14 and 18 PI.
C, capsule; IMC, inner membrane complex; Mo, mosquito tissue; MT, microtubule; Oo, oocyst; PM, plasma membrane; Rb, residual body; SPZ, sporozoite.
DOI: 10.1371/journal.ppat.0010009.g003
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Mutational Analysis of Region IIþ of CS Proteinthe enzyme that cleaves the capsule CS protein is also part of
the capsule. We cannot exclude the possibility that the egress
of sporozoites from oocysts is preceded by a proteolytic
cascade and that ECP1 is only one of the participants.
CS-RIImut Oocysts Sporozoites Are Not Infective to
Mammalian Hosts
As mentioned earlier, in vitro experiments strongly
suggest that the region II-plus of CS protein plays an
important role in the initial stages of sporozoite invasion of
hepatocytes. Initial studies demonstrated that CS protein
binds speciﬁcally to HSPGs in sections of human liver and
that this binding is region II-plus dependent [24,25].
Synthetic peptides representing region II-plus speciﬁcally
inhibit CS protein binding and sporozoite adhesion of
HepG2 cells, the reference cell line that allows sporozoites
to develop into mature exo-erythrocytic forms [26]. This
inhibition is dependant on the downstream positively
charged residues of region II-plus [26]. These and other
ﬁndings (reviewed in [11,12]) give evidence that it is likely
that the lysines and arginines (highly conserved in Plasmodium
species) of region II-plus form ionic bonds with the
negatively charged sulfate molecules of the HSPG glycosa-
minoglycan chains (GAGs). Our region II-plus mutant
provided an opportunity to conﬁrm the in vitro studies
using a genetic approach. The wild-type and mutant
sporozoites obtained by mechanical disruption of the
midguts were incubated brieﬂy with HepG2 cells to compare
their binding to host cells. The sporozoites were obtained at
a time when they are fully developed but not yet egressing
from oocysts. There was a signiﬁcant difference (;40%) in
the binding of wild-type and mutant sporozoites (Figure 5).
We emphasize that this assay was performed under static
condition. The shear force generated by circulating blood in
vivo should lead to more dramatic decrease in adhesion of
mutant sporozoites to cells, as shown previously in vitro
when the attachment assay was performed under rotating
conditions [12]. Indeed, this is what we observed when we
compared the infectivity of oocyst sporozoites from CS-WT
and CS-RIImut to rats. The CS-WT and CS-RIImut spor-
ozoites were injected intravenously into rats, and the pre-
patent period of infection (time until the proportion of
infected erythrocytes is less than 0.01%) measured. In two
independent experiments, there was no infection in rats
injected with 1–9 million CS-RIImut oocyst sporozoites
(Table 2). In contrast, blood-stage parasites were detected
Figure 4. In Vitro Oocyst Sporozoite Release Assay
Release of oocyst sporozoites at 25 8C in vitro in the presence of trypsin
(50 lg/ml) at day 14 PI. Y-axis represents released sporozoites as a
percentage of total oocyst sporozoites. X-axis indicates the time point
when the samples are collected. In the absence of the trypsin, very few
sporozoites are released from the midguts. In the presence of the trypsin,
oocyst sporozoites from both CS-WT (WT) and CS-RIImut (RII) are
released in a time-dependent manner. Compared with CS-WT, CS-RIImut
sporozoites are released more slowly.
DOI: 10.1371/journal.ppat.0010009.g004
Figure 5. Region II-plus is Important for Sporozoite Adhesion to HepG2
Cells
Midgut sporozoites of CS-WT and CS-RIImut (100,000 each) were added
to confluent HepG2 cells. Adhesion is shown as the mean number of
bound sporozoites in one microscopic field (4003magnification). Results
are from three independent experiments.
DOI: 10.1371/journal.ppat.0010009.g005
Table 2. Infectivity of Sporozoites
Experiment Parasite
Clones
Injected
Parasites/
Animal
Infected/
Total
Animals
Prepatent
Period
a
Exp1
CS-RIImut midgut
sporozoites
1,000,000
9,000,000
0/3
0/2
—
—
CS-WT midgut
sporozoites
1,000,000
5,000,000
3/3
2/2
5d
5d
CS-WT salivary
gland sporozoites
20,000
2,000
1/1
1/1
5d
5d
Exp2
CS-RIImut midgut
sporozoites
1,000,000
5,000,000
0/2
0/2
—
—
CS-WT midgut
sporozoites
100,000
1,000,000
2/2
2/2
7.5 d
6d
CS-WT salivary
gland sporozoites
50,000
5,000
1/1
1/1
4d
5d
aPrepatent period is the number of days between injection and first appearance of the parasites in the peripheral
blood.
DOI: 10.1371/journal.ppat.0010009.t002
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Mutational Analysis of Region IIþ of CS Proteinin all rats injected with as few as 100,000 CS-WT oocyst
sporozoites or 2,000 CS-WT salivary gland sporozoites [27].
Tewari et al. [28] also investigated the function of CS
regions II-plus. In their study, the mutation was introduced
in a P. berghei line in which the endogenous CS (PbCS) had
been replaced by P. falciparum CS (PfCS), leading to a
substantial decrease in parasite infectivity [29,30]. In their
studies, Tewari et al. deleted the entire region II-plus of CS
protein, including two of the four cysteines of the CS
thrombospondin domain, and noted that the mutants did not
enter the salivary glands. However, they did not measure the
number of parasites in the mosquito hemocoel. It is possible
therefore that the Tewari’s mutant has the same phenotype
as ours.
We conclude that the same CS protein motif participates in
two different stages of the sporozoite lifecycle. Region II-plus
is ﬁrst required for sporozoite egress from oocysts. Later it is
required for the invasion of the mammalian hepatocytes. It is
tempting to speculate that receptors for region II-plus are
identical in the mammalian host liver and in the oocysts
capsule/basal lamina in the mosquito midgut, i.e., they are
HSPGs. The presence of HSPGs has been documented in
Drosophila [31], and HSPG core proteins are represented in
the Anopheles genome (http://www.ensembl.org) but have not
yet been characterized biochemically. Perhaps capsule/basal
lamina HSPGs interact with the positively charged stretch of
amino acids of CS region II-plus, and the disruption of those
peptide bonds by the newly identiﬁed cysteine protease
(ECP1), or other participating proteases in the same
proteolytic cascade, is an early and necessary step for
sporozoite egress from oocysts.
Materials and Methods
Parasite. The parasite is a wild-type pyrimethamine-sensitive,
gametocyte-producing clone of the P. berghei NK65 strain.
DNA construct and mutagenesis. pQWCS-WT contains pUC19
backbone and 2.8 kb of CS cassette [32] cloned into XbaI and XhoI
sites. Mutations were introduced into the CS coding region by using
QuikChange Site-Directed Mutagenesis Kit (Stratagene, La Jolla,
California, United States). Primer1 (sense, 59-GGTATAA-
GAGTTGCTGCAGCAGCAGGTTCAAATAAGAAAGC-39) and its re-
verse and complement primer2 were used to mutate R290, K291,
R292, and K293 to alanines. The resulting construct is named
‘‘pQWCS-RIImut.’’
Targeting construct. pMD205GFP is used as a backbone to
generate targeting constructs, pRCS-WT and pRCS-RIImut.
pMD205GFP contains the mutated copy of P. berghei DHFR-TS gene
that confers resistance to pyrimethamine [33] and an Aequorea victoria
green-ﬂuorescent protein open reading frame (ORF) [34], and 2.2 kb
and 0.55 kb of 59- and 39UTRs of P. berghei DHFR-TS. pQWCS-WT was
digested with KpnI and XhoI to release the 2.1-kb fragment
containing the CS cassette (0.6 kb of 59UTR, 1-kb CS protein ORF
and 0.5-kb 39UTR). Subsequently, this fragment was cloned into
pMD205GFP treated with same restriction enzymes to generate the
intermediate construct pCS-WT. Targeting construct pRCS-WT was
constructed by cloning a 0.6-kb BamHI-NotI fragment of CS 39UTR
(500–1,100 base pairs downstream of the stop codon) into the pCS-
WT treated with the same restriction enzymes. Targeting construct
pRCS-RIImut was constructed in the same way as pRCS-WT.
Parasite transfection and genotype analysis. Schizonts were
collected for transfection, and targeting constructs were introduced
by electroporation as previous described [33]. Southern blotting was
performed with the entire CS ORF and 0.6-kb 59UTR as a probe. The
probe was labeled with DIG-ddUTP by random priming, and the
chemiluminescence was detected using CSPD (Roche, Basel, Switzer-
land). Speciﬁc ampliﬁcation of the 59 recombinant locus was
preformed with a forward primer CS1 (sense: 59-CTTTTTCACCCT-
CAAGTTGGG-39, which hybridizes to the CS 59UTR missing in the
pRCS-WT/pRCS-RIImut), and a reverse primer PB103 (sense, 59-
TAATTATATGTTATTTTATTTCCAC-39, which hybridizes to the
59UTR of DHFR-TS). Speciﬁc ampliﬁcation of the 39 recombinant
locus was preformed with a forward primer PB106 (sense, 59-
TGTGCATGCACATGCATGTA-39, which hybridizes to the 39UTR
of DHFR-TS), and a reverse primer CS4 (sense, 59-CGAAATAAGT-
TACTATTCGTGCCC-39, which hybridizes to the CS 39UTR missing
in the pRCS-WT/pRCS-RIImut).
Mosquito infection and analysis of parasite development. A.
stephensi mosquitoes were fed on infected young Sprague-Dawley rats
and dissected at various days PI. Midgut and salivary gland sporozoite
populations were prepared from the various mosquito compartments
and analyzed as previous described [27]. Hemolymph from each
mosquito was perfused from the hemocoel with RPMI medium via air
displacement from a micro-inoculation capillary inserted through
the neck membrane and into the hemocoel. A small drop was made in
the distal abdominal wall by gently removing the last two segments.
The ﬁrst three drops of perfusate (hemolymph and medium) from
each mosquito were collected. Perfusate from at least 20 mosquitoes
was collected. The number of sporozoites was determined using a
haemocytometer.
Indirect immunoﬂuorescence assays. Oocyst sporozoites were
collected at day 18 PI, centrifuged onto glass slides, and ﬁxed with
4% paraformaldehyde for 20 min at room temperature. Sporozoites
then were pre-incubated in PBS-3% BSA for 1 h at 37 8C followed by
incubation of various anti-CS antibodies for 1 h at 37 8C. Bound anti-
CS was detected with FITC-conjugated anti-mouse IgG.
Western blotting analysis of sporozoite lysates. Protein samples
were analyzed by SDS-PAGE and electrophoretically transferred to
polyvinylidene diﬂuoride membrane. CS-WT and CS-RIImut oocyst
sporozoites on day 14 and 18 PI were collected, resuspended in SDS
sample buffer, and incubated for 5 min at 70 8C prior to loading. The
migrating bands were revealed with antibodies to P. berghei TRAP and
CS protein, followed by horseradish peroxidase–coupled donkey anti-
rabbit, and sheep anti-mouse IgG respectively, and visualized with
enhanced chemiluminescence (ECL; Amersham Bioscience, Little
Chalfont, United Kingdom).
Analysis of sporozoite infectivity. To analyze sporozoite motility,
sporozoites were incubated in 3% BSA-RPMI 1640 medium for 3 h
prior to microscopic examination [3]. To determine the infectivity of
sporozoites in vivo, young Sprague/Dawley rats were injected intra-
venously with sporozoite suspensions in RPMI 1640. The parasitemia
of inoculated rodents was checked daily by a 10-min examination of a
Giemsa-stained blood smear.
Sporozoite attachment assay. A total of 100,000 midgut sporozoites
were added and centrifuged down to conﬂuent HepG2 cells. After 5-
min incubation at 37 8C, cells were washed twice with PBS, and ﬁxed
with 4% formaldehyde. Adherent sporozoites were stained with a
combination of anti-CS 3D11 and goat anti-mouse FITC antibodies.
For each well, 25 microscopic ﬁelds were counted in duplicate using a
4003 magniﬁcation.
In vitro assay of oocyst sporozoite release. Intact midguts were
dissected from either CS-WT– or CS-RIImut–infected mosquitoes.
For each experiment, 10 midguts were incubated at 25 8C in 200-ll
RPMI medium with or without trypsin (50 lg/ml; Sigma, St. Louis,
Missouri, United States). At different time points, 10 ll was taken out
after gentle shaking the tubes, and sporozoites were counted. At the
end of the experiment, the midguts were ground in order to
determine the mean number of remaining oocyst sporozoites per
mosquito.
Transmission electron microscopy. P. berghei (CS-WT and CS-
RIImut) oocysts within mosquito midguts were ﬁxed with 2.5%
glutaraldehyde in 0.05 M phosphate buffer (pH 7.4) with 4% sucrose
for 2 h. and then post-ﬁxed in 1% osmium tetroxide for 1 h. After a
30-min en bloc stain with 1% aqueous uranyl acetate, the cells were
dehydrated in ascending concentrations of ethanol and embedded in
Epon 812. Ultrathin sections were stained with 2% uranyl acetate in
50% methanol and with lead citrate, and then examined in a Zeiss
CEM902 electron microscope.
Immunoelectron microscopy. P. berghei oocysts within mosquito
midguts were ﬁxed with 3% paraformaldehyde, 0.25% glutaraldehyde
in 0.1 M phosphate buffer (pH 7.4). Fixed samples were washed,
dehydrated, and embedded in LR White resin (Polysciences,
Warrington, Pennsylvania, United States) as described previously
[7]. Thin sections were blocked in PBS containing 0.01% (v/v) Tween-
20 and 5% (w/v) nonfat dry milk (PBTM). Grids were then incubated
for 2 h at room temperature with the primary mouse anti-CS
monoclonal antibody 3D11, and diluted 1:500 in PBTM. Normal
mouse serum or PBTM were used as negative controls. After washing,
grids were incubated for 1 h with 15-nm gold-conjugated goat anti-
mouse IgG (Amersham Life Sciences), diluted 1:20 in PBS containing
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Mutational Analysis of Region IIþ of CS Protein1% (w/v) BSA and 0.01% (v/v) Tween-20, rinsed with Tween-20, and
ﬁxed with glutaraldehyde to stabilize the gold particles. Samples were
stained with uranyl acetate and lead citrate, and then examined in a
Zeiss CEM902 electron microscope.
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